These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2904580)

  • 1. Duodenal ulcer, Campylobacter pylori, and the "leaking roof" concept.
    Goodwin CS
    Lancet; 1988 Dec 24-31; 2(8626-8627):1467-9. PubMed ID: 2904580
    [No Abstract]   [Full Text] [Related]  

  • 2. Bismuth, Campylobacter, and ulcer relapse.
    de Wal J
    Lancet; 1988 Apr; 1(8589):824. PubMed ID: 2895340
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenicity of Campylobacter pylori in the upper gastrointestinal tract--implications for modern therapy.
    Lambert JR; McLean AJ
    Med J Aust; 1989 Aug; 151(3):120-2. PubMed ID: 2755371
    [No Abstract]   [Full Text] [Related]  

  • 4. Cure of duodenal ulcer after eradication of Helicobacter pylori.
    George LL; Borody TJ; Andrews P; Devine M; Moore-Jones D; Walton M; Brandl S
    Med J Aust; 1990 Aug; 153(3):145-9. PubMed ID: 1974027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.
    Marshall BJ; Goodwin CS; Warren JR; Murray R; Blincow ED; Blackbourn SJ; Phillips M; Waters TE; Sanderson CR
    Lancet; 1988 Dec 24-31; 2(8626-8627):1437-42. PubMed ID: 2904568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Campylobacter pylori, duodenal ulcer disease, and gastrin.
    Levi S; Dollery CT; Bloom SR; Calam J; Cox TM; Hodgson HJ; Losowsky MS; Pepys MB; Wright NA; Wrong OM
    BMJ; 1989 Oct; 299(6707):1093-4. PubMed ID: 2511976
    [No Abstract]   [Full Text] [Related]  

  • 7. Colloidal bismuth subcitrate (DE-NOL) and tinidazole healed duodenal ulceration with a low relapse rate due to elimination of Campylobacter pylori.
    Goodwin CS; Marshall BJ; Blackbourn SJ; Warren JR; Phillips M
    J Chemother; 1989 Jul; 1(4 Suppl):838-9. PubMed ID: 16312662
    [No Abstract]   [Full Text] [Related]  

  • 8. Colloidal bismuth in the treatment of duodenal ulceration: the benefit for the patient.
    Miller JP
    Scand J Gastroenterol Suppl; 1989; 157():16-20; discussion 21-2. PubMed ID: 2568684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
    Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
    Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duodenal ulcer relapse after eradication of Campylobacter pylori.
    Marshall BJ; Warren JR; Goodwin CS
    Lancet; 1989 Apr; 1(8642):836-7. PubMed ID: 2564914
    [No Abstract]   [Full Text] [Related]  

  • 11. Duodenal ulcer relapse after eradication of Campylobacter pylori.
    Lam SK
    Lancet; 1989 Feb; 1(8634):384. PubMed ID: 2563535
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.
    Goodwin CS; Marshall BJ; Blincow ED; Wilson DH; Blackbourn S; Phillips M
    J Clin Pathol; 1988 Feb; 41(2):207-10. PubMed ID: 3280609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric metaplasia in duodenal bulb and Campylobacter-like organisms in development of duodenal ulcer.
    Caselli M; Trevisani L; Aleotti A; Bovolenta MR; Stabellini G
    Dig Dis Sci; 1989 Sep; 34(9):1374-8. PubMed ID: 2766904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential impact of Campylobacter pylori on the treatment of duodenal ulcer disease.
    Miller JP; Faragher EB
    Scand J Gastroenterol Suppl; 1989; 160():39-45. PubMed ID: 2573145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Campylobacter pylori as a pathogenetic factor in duodenal ulcer: the case for.
    Graham DY
    Scand J Gastroenterol Suppl; 1989; 160():46-52. PubMed ID: 2814348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of bismuth subsalicylate versus cimetidine on Campylobacter pylori, ulcer healing and rate of recurrence].
    Eberhardt R; Kasper G; Dettmer A; Höchter W; Hagena D
    Med Klin (Munich); 1988 May; 83(12):402-5. PubMed ID: 3043160
    [No Abstract]   [Full Text] [Related]  

  • 17. Cure of duodenal ulcer associated with eradication of Helicobacter pylori.
    Rauws EA; Tytgat GN
    Lancet; 1990 May; 335(8700):1233-5. PubMed ID: 1971318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Campylobacter pylori, duodenal ulcer, and gastric metaplasia: possible role of functional heterotopic tissue in ulcerogenesis.
    Carrick J; Lee A; Hazell S; Ralston M; Daskalopoulos G
    Gut; 1989 Jun; 30(6):790-7. PubMed ID: 2753403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of tripotassium-dicitrato-bismuthate (TDB) and cimetidine in peptic ulcer disease, a control study of 40 gastric ulcer and 80 duodenal ulcer.
    Chearanai O; Kachintorn U; Plengvanit U
    J Med Assoc Thai; 1987 Apr; 70(4):176-80. PubMed ID: 3612003
    [No Abstract]   [Full Text] [Related]  

  • 20. Duodenal bulb biopsy findings for patients with non-ulcer dyspepsia with or without Campylobacter pylori gastritis.
    Frierson HF; Caldwell SH; Marshall BJ
    Mod Pathol; 1990 May; 3(3):271-6. PubMed ID: 2362937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.